태아 모니터링 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Fetal Monitoring Market reached USD 5.8 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2034, driven by the increasing demand for advanced maternal healthcare solutions. Rising awareness of pregnancy-related complications and the need for early detection of fetal distress are key factors propelling market growth. As healthcare providers emphasize proactive maternal and fetal care, the adoption of innovative monitoring technologies is accelerating.

Continuous advancements in medical technology are transforming fetal monitoring, making it more precise, efficient, and accessible. Enhanced sensor accuracy, real-time monitoring capabilities, and AI-driven analytics are revolutionizing prenatal care by enabling early diagnosis and intervention. These innovations not only improve pregnancy outcomes but also reduce the risk of complications, ensuring better overall maternal and fetal health. The growing integration of remote monitoring and telehealth solutions further enhances accessibility, particularly in regions with limited healthcare infrastructure. As digital health adoption rises, healthcare providers are leveraging data-driven insights to deliver personalized and timely interventions.

Portability remains a crucial factor in market segmentation, distinguishing devices into portable and non-portable categories. In 2024, portable fetal monitoring devices accounted for 37.9% of the market share, driven by their convenience and mobility. This segment is projected to grow at a CAGR of 6.9% through 2034, reflecting a rising preference for home-based and outpatient fetal monitoring. Portable devices enable continuous monitoring without frequent hospital visits, enhancing prenatal care management for both healthcare professionals and expectant mothers. As a result, these solutions are streamlining maternal healthcare services while reducing the burden on hospital facilities.

Segmentation by method highlights the increasing preference for non-invasive fetal monitoring over traditional invasive techniques. In 2024, non-invasive solutions dominated the market with a 76% share, and this segment is expected to witness the highest growth in the coming years. Non-invasive technologies offer accurate fetal monitoring while eliminating risks associated with invasive methods, such as infections and bleeding. The growing demand for safe, efficient, and comfortable monitoring solutions is reinforcing the shift toward non-invasive options, particularly in developed healthcare markets.

The United States remains a dominant player in the global fetal monitoring industry, generating USD 2 billion in revenue in 2024. The increasing incidence of pregnancy-related complications is a primary factor driving demand across the country. As healthcare systems focus on risk management and early intervention, the adoption of advanced fetal monitoring solutions continues to expand. The integration of AI-powered diagnostics and wireless monitoring further strengthens market growth, enhancing patient care standards while optimizing healthcare resources. With continuous innovation and supportive regulatory frameworks, the US fetal monitoring market is poised for sustained expansion in the coming decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of pregnancy-related complications
    • 3.2.1.2 Technological advancements in fetal monitoring devices
    • 3.2.1.3 Rising government initiatives aimed at promoting maternal and child health
    • 3.2.1.4 Surge in adoption of non-invasive devices
    • 3.2.1.5 Increasing number of preterm births and rising adoption of infertility treatment
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Availability of refurbished products
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Ultrasound devices
  • 5.2.1 2D ultrasound
  • 5.2.2 3D and 4D ultrasound
  • 5.2.3 Doppler imaging
• 5.3 Electronic fetal monitoring (EFM)
  • 5.3.1 External EFM
  • 5.3.2 Internal EFM
• 5.4 Uterine contraction monitor
• 5.5 Accessories and consumables
• 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Portability, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Portable
• 6.3 Non-portable

Chapter 7 Market Estimates and Forecast, By Method, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Invasive
• 7.3 Non-invasive

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Becton, Dickinson and Company
• 10.2 Biolight Medical
• 10.3 Cardinal Health
• 10.4 DOTO Health
• 10.5 EDAN Instrument
• 10.6 FUJIFILM Holdings Corporation
• 10.7 GE Healthcare
• 10.8 Huntleigh Healthcare (Arjo)
• 10.9 Koninklijke Philips
• 10.10 MedGyn products
• 10.11 Medtronic
• 10.12 Natus Medical
• 10.13 Neoventa Medical
• 10.14 Siemens Healthineers
• 10.15 Spacelabs Healthcare